{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:31:54Z","timestamp":1791415914338,"version":"4.3.3"},"reference-count":52,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.vaccine.2013.03.005","type":"journal-article","created":{"date-parts":[[2013,3,13]],"date-time":"2013-03-13T06:30:29Z","timestamp":1363156229000},"page":"2246-2252","source":"Crossref","is-referenced-by-count":49,"title":["Preventive and therapeutic DNA vaccination partially protect dogs against an infectious challenge with Trypanosoma cruzi"],"prefix":"10.1016","volume":"31","author":[{"given":"Israel A.","family":"Quijano-Hern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Castro-Barcena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan C.","family":"V\u00e1zquez-Chagoy\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel E.","family":"Bolio-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Ortega-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Dumonteil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2013.03.005_bib0005","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/S0140-6736(10)60061-X","article-title":"Chagas disease","volume":"375","author":"Rassi","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2013.03.005_bib0010","doi-asserted-by":"crossref","first-page":"e1498","DOI":"10.1371\/journal.pntd.0001498","article-title":"Chagas disease: \u201cthe new HIV\/AIDS of the Americas\u201d","volume":"6","author":"Hotez","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2013.03.005_bib0015","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1590\/S0036-36341999000400010","article-title":"Update on Chagas\u2019 disease in Mexico","volume":"41","author":"Dumonteil","year":"1999","journal-title":"Salud Publica Mex"},{"key":"10.1016\/j.vaccine.2013.03.005_bib0020","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1191\/0960327106het653oa","article-title":"Toxic side effects of drugs used to treat Chagas\u2019 disease (American trypanosomiasis)","volume":"25","author":"Castro","year":"2006","journal-title":"Hum Exp Toxicol"},{"key":"10.1016\/j.vaccine.2013.03.005_bib0025","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1136\/bmj.b1283","article-title":"Eliminating Chagas disease: challenges and a roadmap","volume":"338","author":"Reithinger","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2013.03.005_bib0030","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/hdy.2011.71","article-title":"Genetics and evolution of triatomines: from phylogeny to vector control","volume":"108","author":"Gourbi\u00e8re","year":"2012","journal-title":"Heredity"},{"key":"10.1016\/j.vaccine.2013.03.005_bib0035","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.4161\/hv.7.11.17016","article-title":"Advances and challenges towards a vaccine against Chagas disease","volume":"7","author":"Quijano-Hernandez","year":"2011","journal-title":"Human Vaccines"},{"key":"10.1016\/j.vaccine.2013.03.005_bib0040","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1586\/erv.12.85","article-title":"Accelerating the development of a therapeutic vaccine for human Chagas disease: rationale and prospects","volume":"11","author":"Dumonteil","year":"2012","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2013.03.005_bib0045","doi-asserted-by":"crossref","first-page":"e916","DOI":"10.1371\/journal.pntd.0000916","article-title":"The potential economic value of a Trypanosoma cruzi (Chagas disease) vaccine in Latin America","volume":"4","author":"Lee","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2013.03.005_bib0050","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.4161\/hv.20966","article-title":"Modeling the economic value of a Chagas\u2019 disease therapeutic vaccine","volume":"8","author":"Lee","year":"2012","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.vaccine.2013.03.005_bib0055","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1017\/S0031182006001259","article-title":"Domestic dogs and cats as sources of Trypanosoma cruzi infection in rural northwestern Argentina","volume":"134","author":"Gurtler","year":"2007","journal-title":"Parasitology"},{"key":"10.1016\/j.vaccine.2013.03.005_bib0060","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.actatropica.2006.05.006","article-title":"Infected dogs as a risk factor in the transmission of human Trypanosoma cruzi infection in western Venezuela","volume":"98","author":"Crisante","year":"2006","journal-title":"Acta Trop"},{"key":"10.1016\/j.vaccine.2013.03.005_bib0065","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1590\/S0036-46652002000500008","article-title":"Quantitative analysis of cardiac lesions in chronic canine chagasic cardiomyopathy","volume":"44","author":"Caliari","year":"2002","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"10.1016\/j.vaccine.2013.03.005_bib0070","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.vetpar.2009.02.024","article-title":"Immunopathology of natural Trypanosoma cruzi infection in dogs","volume":"162","author":"Cruz-Chan","year":"2009","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.vaccine.2013.03.005_bib0075","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1590\/S0074-02761992000100011","article-title":"Experimental Chagas\u2019 disease in dogs","volume":"87","author":"de Lana","year":"1992","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.vaccine.2013.03.005_bib0080","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0001-706X(02)00139-0","article-title":"The dog as model for chemotherapy of the Chagas\u2019 disease","volume":"84","author":"Guedes","year":"2002","journal-title":"Acta Trop"},{"key":"10.1016\/j.vaccine.2013.03.005_bib0085","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0020-7519(01)00158-8","article-title":"Parasite persistence in the aetiology of Chagas disease","volume":"31","author":"Tarleton","year":"2001","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.vaccine.2013.03.005_bib0090","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1590\/S0100-879X2011007500005","article-title":"Evasion of immune responses by Trypanosoma cruzi, the etiological agent of Chagas disease","volume":"44","author":"DosReis","year":"2011","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.vaccine.2013.03.005_bib0095","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.coi.2009.07.006","article-title":"CD8+ T cells in Trypanosoma cruzi infection","volume":"21","author":"Padilla","year":"2009","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2013.03.005_bib0100","doi-asserted-by":"crossref","first-page":"90520","DOI":"10.1155\/2007\/90520","article-title":"DNA vaccines against protozoan parasites: opportunities and challenges","volume":"2007","author":"Dumonteil","year":"2007","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.vaccine.2013.03.005_bib0105","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1590\/S0100-879X1999000200013","article-title":"Trans-sialidase delivered as a naked DNA vaccine elicits an immunological response similar to a Trypanosoma cruzi infection","volume":"32","author":"Costa","year":"1999","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.vaccine.2013.03.005_bib0110","doi-asserted-by":"crossref","first-page":"5547","DOI":"10.1128\/IAI.70.10.5547-5555.2002","article-title":"Genetic immunization elicits antigen-specific protective immune responses and decreases disease severity in Trypanosoma cruzi infection","volume":"70","author":"Garg","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.03.005_bib0115","doi-asserted-by":"crossref","first-page":"5073","DOI":"10.1128\/IAI.66.11.5073-5081.1998","article-title":"Vaccination with trypomastigote surface antigen 1-encoding plasmid DNA confers protection against lethal Trypanosoma cruzi infection","volume":"66","author":"Wizel","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.03.005_bib0120","doi-asserted-by":"crossref","first-page":"4986","DOI":"10.1128\/IAI.68.9.4986-4991.2000","article-title":"DNA-Based immunization with Trypanosoma cruzi complement regulatory protein elicits complement lytic antibodies and confers protection against Trypanosoma cruzi infection","volume":"68","author":"Sepulveda","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.03.005_bib0125","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1016\/S0264-410X(03)00121-X","article-title":"Genetic immunization with LYT1 or a pool of trans-sialidase genes protects mice from lethal Trypanosoma cruzi infection","volume":"21","author":"Fralish","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.03.005_bib0130","doi-asserted-by":"crossref","first-page":"e983","DOI":"10.1371\/journal.pntd.0000983","article-title":"Co-administration of a plasmid DNA encoding IL-15 improves long-term protection of a genetic vaccine against Trypanosoma cruzi","volume":"5","author":"Eickhoff","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2013.03.005_bib0135","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1128\/IAI.01190-10","article-title":"Heterologous plasmid DNA prime-recombinant human adenovirus 5 boost vaccination generates a stable pool of protective long-lived CD8(+) T effector memory cells specific for a human parasite Trypanosoma cruzi","volume":"79","author":"Rigato","year":"2011","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.03.005_bib0140","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1128\/IAI.72.1.46-53.2004","article-title":"Immunotherapy of Trypanosoma cruzi infection with DNA vaccines in mice","volume":"72","author":"Dumonteil","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.03.005_bib0145","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1574-695X.2007.00251.x","article-title":"Comparative efficacy of DNA vaccines encoding various Trypanosoma cruzi antigens","volume":"50","author":"Sanchez-Burgos","year":"2007","journal-title":"FEMS Microbiol Med Immunol"},{"key":"10.1016\/j.vaccine.2013.03.005_bib0150","doi-asserted-by":"crossref","first-page":"7414","DOI":"10.1016\/j.vaccine.2010.08.104","article-title":"Effect of a combination DNA vaccine for the prevention and therapy of Trypanosoma cruzi infection in mice: role of CD4+ and CD8+ T cells","volume":"28","author":"Limon-Flores","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.03.005_bib0155","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.1016\/j.vaccine.2007.01.114","article-title":"Vaccination with Trypanosoma rangeli reduces the infectiousness of dogs experimentally infected with Trypanosoma cruzi","volume":"25","author":"Basso","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.03.005_bib0160","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1196\/annals.1428.098","article-title":"vaccine against Trypansomoma cruzi in dogs: a pilot clinical trial","volume":"1149","author":"Quijano-Hernandez","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.vaccine.2013.03.005_bib0165","doi-asserted-by":"crossref","first-page":"e1050","DOI":"10.1371\/journal.pntd.0001050","article-title":"Testing the efficacy of a multi-component DNA-prime\/DNA-boost vaccine against Trypanosoma cruzi infection in dogs","volume":"5","author":"Aparicio-Burgos","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2013.03.005_bib0170","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0264-410X(99)00151-6","article-title":"Enhancement of DNA vaccine potency using conventional aluminum adjuvants","volume":"18","author":"Ulmer","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.03.005_bib0175","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/S0264-410X(99)00391-6","article-title":"Enhanced type I immune response to a hepatitis B DNA vaccine by formulation with calcium- or aluminium phosphate","volume":"18","author":"Wang","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.03.005_bib0180","doi-asserted-by":"crossref","first-page":"5372","DOI":"10.1016\/j.vaccine.2005.05.037","article-title":"Aluminium phosphate potentiates DNA vaccines against Leishmania mexicana","volume":"23","author":"Rosado-Vallado","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.03.005_bib0185","series-title":"Outline of veterinary clinical pathology","first-page":"261","article-title":"Normal blood values in equine, bovine, ovine, caprine, ovine, canine and feline","author":"Maxine","year":"1978"},{"key":"10.1016\/j.vaccine.2013.03.005_bib0190","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1146\/annurev.nutr.012809.104804","article-title":"Iron homeostasis and the inflammatory response","volume":"30","author":"Wessling-Resnick","year":"2010","journal-title":"Annu Rev Nutr"},{"key":"10.1016\/j.vaccine.2013.03.005_bib0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2011.08.012","article-title":"Prognostic significance of anemia in patients with chronic systolic heart failure secondary to Chagas\u2019 cardiomyopathy","author":"Miguel","year":"2011","journal-title":"Acta Trop"},{"key":"10.1016\/j.vaccine.2013.03.005_bib0200","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ijcard.2009.04.011","article-title":"Eosinophil blood count and anemia are associated with Trypanosoma cruzi infection reactivation in Chagas\u2019 heart transplant recipients","volume":"145","author":"Theodoropoulos","year":"2010","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.vaccine.2013.03.005_bib0205","doi-asserted-by":"crossref","first-page":"143","DOI":"10.4269\/ajtmh.1993.49.143","article-title":"Field trial of vaccination against American trypanosomiasis (Chagas\u2019 disease) in dogs","volume":"49","author":"Basombrio","year":"1993","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2013.03.005_bib0210","doi-asserted-by":"crossref","first-page":"954","DOI":"10.2460\/ajvr.1991.52.06.954","article-title":"Clinical, clinicopathologic, and parasitologic observations of trypanosomiasis in dogs infected with North American Trypanosoma cruzi isolates","volume":"52","author":"Barr","year":"1991","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.vaccine.2013.03.005_bib0215","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.meegid.2012.04.024","article-title":"Extensive diversity of Trypanosoma cruzi discrete typing units circulating in Triatoma dimidiata from central Veracruz Mexico","volume":"12","author":"Ramos-Ligonio","year":"2012","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.vaccine.2013.03.005_bib0220","doi-asserted-by":"crossref","first-page":"5644","DOI":"10.1016\/j.vaccine.2009.07.013","article-title":"Strain-specific protective immunity following vaccination against experimental Trypanosoma cruzi infection","volume":"27","author":"Haolla","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.03.005_bib0225","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1128\/JCM.33.8.2086-2090.1995","article-title":"Use of a 24-kilodalton Trypanosoma cruzi recombinant protein to monitor cure of human Chagas\u2019 disease","volume":"33","author":"Krautz","year":"1995","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2013.03.005_bib0230","doi-asserted-by":"crossref","first-page":"e25914","DOI":"10.1371\/journal.pone.0025914","article-title":"Genomic analyses, gene expression and antigenic profile of the trans-sialidase superfamily of Trypanosoma cruzi reveal an undetected level of complexity","volume":"6","author":"Freitas","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2013.03.005_bib0235","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1371\/journal.ppat.0020077","article-title":"CD8+ T-Cell responses to Trypanosoma cruzi are highly focused on strain-variant trans-sialidase epitopes","volume":"2","author":"Martin","year":"2006","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2013.03.005_bib0240","doi-asserted-by":"crossref","first-page":"e288","DOI":"10.1371\/journal.pntd.0000288","article-title":"HLA Class I-T cell epitopes from trans-sialidase proteins reveal functionally distinct subsets of CD8+ T cells in chronic Chagas disease","volume":"2","author":"Alvarez","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2013.03.005_bib0245","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1128\/CVI.00144-08","article-title":"Previously unrecognized vaccine candidates control Trypanosoma cruzi infection and immunopathology in mice","volume":"15","author":"Bhatia","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2013.03.005_bib0250","doi-asserted-by":"crossref","first-page":"e797","DOI":"10.1371\/journal.pntd.0000797","article-title":"Prophylactic efficacy of TcVac2 against Trypanosoma cruzi in mice","volume":"4","author":"Gupta","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2013.03.005_bib0255","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1017\/S1462399410001560","article-title":"The endless race between Trypanosoma cruzi and host immunity: lessons for and beyond Chagas disease","volume":"12","author":"Junqueira","year":"2010","journal-title":"Expert Rev Mol Med"},{"key":"10.1016\/j.vaccine.2013.03.005_bib0260","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.imlet.2005.11.015","article-title":"Control of Trypanosoma cruzi infection and changes in T cell populations induced by a therapeutic DNA vaccine in mice","volume":"103","author":"Zapata-Estrella","year":"2006","journal-title":"Immunol Lett"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13002648?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13002648?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T10:14:12Z","timestamp":1715076852000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13002648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":52,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0264410X13002648"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.03.005","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}